160 related articles for article (PubMed ID: 1916034)
1. Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring.
Savarino V; Mela GS; Zentilin P; Sumberaz A; Cutela P; Celle G
Digestion; 1991; 48(3):141-8. PubMed ID: 1916034
[TBL] [Abstract][Full Text] [Related]
2. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nocturnal acidity is important but not essential for duodenal ulcer healing.
Bianchi Porro G; Parente F; Sangaletti O
Gut; 1990 Apr; 31(4):397-400. PubMed ID: 2186980
[TBL] [Abstract][Full Text] [Related]
4. Mealtime versus nighttime acid inhibition. A clinical pharmacological study with ranitidine.
Savarino V; Mela GS; Zentilin P; Vigneri S; Cutela P; Mele R; Di Mario F
Dig Dis Sci; 1992 Sep; 37(9):1368-72. PubMed ID: 1505287
[TBL] [Abstract][Full Text] [Related]
5. Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer.
Savarino V; Mela GS; Scalabrini P; Di Timoteo E; Magnolia MR; Celle G
Digestion; 1987; 37(2):103-9. PubMed ID: 3305114
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
[TBL] [Abstract][Full Text] [Related]
7. Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg.
Savarino V; Mela GS; Zentilin P; Cutela P; Mele R; Celle G
J Clin Pharmacol; 1993 Jan; 33(1):70-4. PubMed ID: 8429117
[TBL] [Abstract][Full Text] [Related]
8. Single dose ranitidine: influence of the time of administration on gastric acidity in normal subjects and in patients with duodenal ulcer.
Coppens JP; Warzee P; Schapira M; Fiasse R; Dive C
Gastroenterol Clin Biol; 1988; 12(6-7):537-41. PubMed ID: 3417080
[TBL] [Abstract][Full Text] [Related]
9. Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring.
Celle G; Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P
Scand J Gastroenterol; 1988 May; 23(4):385-90. PubMed ID: 2898167
[TBL] [Abstract][Full Text] [Related]
10. [Does nocturnal monitoring of gastric pH permit the prediction of therapeutic response in severe duodenal ulcer treated with ranitidine?].
Galmiche JP; Tranvouez JL; Denis P; N'Djitoyap C; Guillard JF; Lehur PA; Colin R
Gastroenterol Clin Biol; 1985; 9(8-9):583-9. PubMed ID: 4076717
[TBL] [Abstract][Full Text] [Related]
11. Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment.
Savarino V; Mela GS; Zentilin P; Cutela P; Mansi C; Vassallo A; Franceschi M; Mela MR; Dallorto E; Celle G
Am J Gastroenterol; 1993 Jul; 88(7):1088-92. PubMed ID: 8317411
[TBL] [Abstract][Full Text] [Related]
12. Twenty-four-hour intragastric acidity in duodenal ulcer patients during dosing with placebo, and 150 mg ranitidine twice or four times daily.
Howden CW; Tsai HH; Reid JL
Aliment Pharmacol Ther; 1989 Jun; 3(3):253-8. PubMed ID: 2520620
[TBL] [Abstract][Full Text] [Related]
13. Is the inhibition of nocturnal gastric acid secretion the most important factor in duodenal ulcer treatment? A comparison between the effectiveness of single morning and nocte doses of ranitidine 300 mg.
Zaterka S; Massuda HK; Eisig JN; Chinzon D; Bettarello A
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):185-8. PubMed ID: 2700103
[TBL] [Abstract][Full Text] [Related]
14. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
[TBL] [Abstract][Full Text] [Related]
15. A double-blind randomized study comparing different dose regimens of H2-receptor antagonists on 24-hour gastric secretion in normal subjects and duodenal ulcer patients.
de Gara CJ; Burget DW; Silletti C; Hunt RH
Am J Gastroenterol; 1987 Jan; 82(1):36-41. PubMed ID: 3099564
[TBL] [Abstract][Full Text] [Related]
16. Ranitidine in the treatment of duodenal ulcer disease: relationship between antisecretory effect and ulcer healing rate.
McIsaac RL; Dixon JS; Mills JG; Wood JR
Aliment Pharmacol Ther; 1991 Jun; 5(3):227-43. PubMed ID: 1888823
[TBL] [Abstract][Full Text] [Related]
17. Night-time or morning dosing with H2-receptor antagonists: studies on acid inhibition in normal subjects.
Patel N; Ward U; Rogers MJ; Primrose JN
Aliment Pharmacol Ther; 1992 Jun; 6(3):381-7. PubMed ID: 1600054
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ranitidine 300 mg twice daily, 300 mg at night and placebo on 24-hour intragastric acidity of duodenal ulcer patients.
Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Kaufmann D; Mappes A; Heim J; Röhmel J
Aliment Pharmacol Ther; 1987 Jun; 1(3):217-23. PubMed ID: 2979224
[TBL] [Abstract][Full Text] [Related]
19. Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer.
Savarino V; Mela GS; Zentilin P; Bonifacino G; Moretti M; Valle F; Celle G
Dig Dis Sci; 1989 Jul; 34(7):1043-6. PubMed ID: 2568246
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandins and peptic ulcer disease: nocturnal administration of rioprostil vs ranitidine in duodenal ulcer healing.
Simon B; Dammann HG; Müller P
Klin Wochenschr; 1986; 64 Suppl 7():44-6. PubMed ID: 3104657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
